Frontlight ResearchEarly access
Taking people in United StatesNo phase
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
Key facts
- Who runs it
- Krystal Biotech, Inc.
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 2 Aug 2024
- Planned end
- Dec 2025
- Type of study
- Observational
- Record updated
- 2 July 2025
Who can take part
- Age
- 6 months and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- The subject or their respective legal guardian must have read, understood, and signed an Institutional Review Board (IRB) approved Informed Consent/Assent Form and must be able to and willing to follow study procedures and instructions
- Age 6 months or older at time of Informed Consent/Assent
- Prior genetic diagnosis of DEB due to mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene
Where in United States
- Krystal BiotechPittsburgh, United StatesContact: Brittani AgostiniTaking people
About the trial
What the trial wants to find out
This study is a non-interventional, observational study that will evaluate the natural history of corneal abrasions in patients with Dystrophic Epidermolysis Bullosa (DEB).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 2 July 2025